Chrome Extension
WeChat Mini Program
Use on ChatGLM

Global Epidemiology of Acute Kidney Injury in Hospitalised Patients with Decompensated Cirrhosis: the International Club of Ascites GLOBAL AKI Prospective, Multicentre, Cohort Study.

Kavish R Patidar, Ann T MaSalvatore Piano, International Club of Ascites GLOBAL AKI team

The lancet Gastroenterology & hepatology(2025)

Toronto Centre for Liver Disease | Liver Unit | Department of Hepatology | Baylor University Medical Center | Division of Gastroenterology and Hepatology | Department of Tropical Medicine | Department of Gastroenterology and Hepatology | Department of Gastroenterology | Central Military Hospital | Departamento del Aparato Digestivo | Institute of Liver and Biliary Sciences | Hepatology and Gastroenterology Unit | Gastroenterology and Hepatology Department | Department of Medicine II | Gastroenterology and Hepatology Unit | Department of Medical and Surgical Sciences | Department of Internal Medicine | Departamento de Gastroenterología | Gastroenterology Unit | Department of Translational and Precision Medicine | Gastro Unit | Institute of Clinical Research | Servicio de Gastroenterología | Medical Department III | Addis Ababa University | Liver Research Centre Ghent | Ente Ospedaliero Cantonale | Department of Medicine | Hepatology and Liver Intensive Care

Cited 0|Views1
Abstract
BACKGROUND:Acute kidney injury (AKI) is a serious complication of cirrhosis. A systematic, global characterisation of AKI occurring in patients with cirrhosis is lacking. We therefore aimed to assess global differences in the characteristics, management, and outcomes of AKI in hospitalised patients with cirrhosis. METHODS:In this prospective, multicentre, cohort study, we enrolled adults (≥18 years) with decompensated cirrhosis who were hospitalised for a cirrhosis-related complication, with or without AKI, at 65 centres across five continents. We captured AKI prevalence, stage, phenotype, and details on AKI management and clinical course. Universal health coverage index and gross national income per capita were also collected. The primary outcome was 28-day mortality. Multivariable models including demographic and clinical variables, cirrhosis cause, cirrhosis severity, AKI severity, AKI management variables, universal health coverage, and gross national income were used to analyse independent associations with 28-day mortality. Secondary outcomes were AKI classification, progression, and resolution. This study is complete and registered with ClinicalTrials.gov (NCT05387811). FINDINGS:Between July 1, 2022, and May 31, 2023, we enrolled 3821 patients who were hospitalised for decompensated cirrhosis. Mean age was 57·7 years (SD 13·1), 2467 (64·6%) were men, and 1354 (35·4%) were women. Most patients were White (2128 [55·7%]). 1456 (38·1%, 95% CI 36·6-39·6) of 3821 patients had AKI (943 [64·8%] men and 513 [35·2%] women). Globally, patients presented with similar AKI stages, but patients from North America and Asia had the highest MELD-Na scores at presentation and the highest rates of peak AKI stage 3. Overall, hypovolaemic AKI was the most common phenotype (858 [58·9%] of 1456), followed by HRS-AKI (253 [17·4%]) and acute tubular necrosis (216 [14·8%]). The prevalences of hypovolaemic AKI and HRS-AKI were similar across regions, but acute tubular necrosis was more frequent in Asia (p<0·0001 across regions). Additionally, regional differences in the management of AKI (use of albumin, vasopressors, and diuretics) were found. 335 (28·6%) of 1171 patients with initial AKI stages 1 or 2 had progression to higher stages during hospitalisation. AKI resolved in 862 (59·2%) cases during hospitalisation. 333 (22·9%) patients with AKI had died by 28 days. Multivariable analyses showed that increased age, female sex, presence of ascites, presence of hepatic encephalopathy, increased white blood cell count, increased MELD-Na, hospital-acquired AKI, a lower universal health coverage index (<80), and not being in a high-income country were independently associated with an increased risk of 28-day mortality. Increased serum albumin was associated with a decreased risk of 28-day mortality. INTERPRETATION:This study found important regional differences in AKI severity, phenotype, management, and outcomes in patients with decompensated cirrhosis. Health-care coverage remains an important driver of survival in patients with cirrhosis and AKI. FUNDING:European Association Study for the Study of the Liver and the Italian Society of Internal Medicine.
More
Translated text
求助PDF
上传PDF
Bibtex
AI Read Science
AI Summary
AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.
Example
Background
Key content
Introduction
Methods
Results
Related work
Fund
Key content
  • Pretraining has recently greatly promoted the development of natural language processing (NLP)
  • We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
  • We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
  • The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
  • Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance
Upload PDF to Generate Summary
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper

要点】:这项国际多中心队列研究全面评估了住院肝硬化患者急性肾损伤(AKI)的全球流行病学特征、管理方式及预后,发现不同地区在AKI严重程度、表型、治疗及结局上存在显著差异,且医疗保健覆盖范围是影响肝硬化合并AKI患者生存的重要因子。

方法】:研究采用前瞻性、多中心、队列研究方法,纳入了全球五大洲65个中心的≥18岁住院肝硬化患者,无论是否伴有AKI。

实验】:在2022年7月1日至2023年5月31日期间,共招募了3821名因肝硬化失代偿住院的患者。研究发现,38.1%的患者伴有AKI,其中以低血容量AKI最为常见。住院期间,28.6%的初始AKI 1或2期患者病情加重,59.2%的AKI病例得到解决,22.9%的AKI患者28天内死亡。研究在ClinicalTrials.gov(NCT05387811)上注册并已完成。